Global Vipera Berus Venom Market Outlook
Revenue, 2024
Forecast, 2034
CAGR, 2024 - 2034
The venom of Vipera Berus is obtained from the adder and is esteemed for its valuable qualities in various fields such as healthcare and scientific exploration. Its cytotoxicity, fight against microbes. Pain relieving features have been harnessed in creating drugs that combat cancer and alleviate pain. Moreover the growing application of this venom in research for tackling neurodegenerative diseases and developing antiplatelet medications has led to an increase, in demand.
Market Key Insights
- The Vipera Berus Venom market is projected to grow from $797.4 million in 2024 to $2.26 billion in 2034. This represents a CAGR of 11%, reflecting rising demand across Medicinal Use, Cosmetic and Biomedical Research.
- Venomex Company, Exotic Venom International, Serpents Kiss Ltd are among the leading players in this market, shaping its competitive landscape.
- U.S. and Germany are the top markets within the Vipera Berus Venom market and are expected to observe the growth CAGR of 8.0% to 11.6% between 2024 and 2030.
- Emerging markets including Brazil, South Korea and UAE are expected to observe highest growth with CAGR ranging between 10.6% to 13.8%.
- Transition like Emergence in Cosmetics is expected to add $204.2 million to the Vipera Berus Venom market growth by 2030
- The Vipera Berus Venom market is set to add $1.5 billion between 2024 and 2034, with manufacturer targeting Cosmetics & Biomedical Research End-Use Applications projected to gain a larger market share.
- With Rising demand in pharmaceuticals, and Technological advancements in venom extraction, Vipera Berus Venom market to expand 184% between 2024 and 2034.
Opportunities in the Vipera Berus Venom
Vipera Berous Venom is considered a substance with great therapeutic possibilities being explored for various health conditions like chronic pain and cancer among others, through ongoing research and development efforts aimed at discovering new uses for this venomous compound.
Growth Opportunities in North America and Europe
North America Outlook
Europe Outlook
Market Dynamics and Supply Chain
Driver: Rising Demand in Pharmaceuticals, and Increasing Scope in Cosmetics Industry
also advances in extracting venom using technology have also made it safer and quicker to obtain Vipera Berus Venom more than ever before. With progress in biotechnology approaches like cultivating venom glands and producing proteins it has also paved the way for new ways to use this venom satisfying the growing demand, in the market.
Restraint: Regulatory Hurdles
Opportunity: Innovation in Cosmeceutical Industry and Strategic Collaborations for Antivenom Production
The increasing incidents of Vipera Berus snakebites worldwide highlight the need for the creation of antivenoms with the potential to save lives and meet market demands effectively through partnerships, between pharmaceutical firms and research facilities paired with venom suppliers.
Challenge: Limited Public Awareness
Supply Chain Landscape
Vipera Labs
Croatian Institute of Immunology
Sigma-Aldrich
Thermo Fisher Scientific
Merck KGaA
GlaxoSmithKline Plc
Pharmaceutical
Health & Wellness industry
Vipera Labs
Croatian Institute of Immunology
Sigma-Aldrich
Thermo Fisher Scientific
Merck KGaA
GlaxoSmithKline Plc
Pharmaceutical
Health & Wellness industry